Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SCIO Scios Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Ian@SI who wrote (1357)	5/25/2001 10:46:10 AM
From: Robert Cohen	Read Replies (1) \| Respond to of 1477

I am not sure what all the hoopla is over Natracor. The study as I understands it compares the effectiveness of the drug with Intravenous Nitroglycerine in the treatment of severe congestive heart failure ie pulmonary edema. In over 20 years of practice as an ER physician I have rarely used IV NTG or Nitroprusside to treat pulmonary edema. In the vast majority of cases the standard therapy consisting of oxygen, elevating the head, sublingual NTG, Nitropaste, Morphine sulfate, and Lasix in various combinations produces a cheap and effective response. Just to make sure that my experience reflects the standard of care I recently polled the other members of my group and my observations were felt to be accurate. Robert